These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 38722338)

  • 1. Quantitative assay to analyze neutralization and inhibition of authentic Middle East respiratory syndrome coronavirus.
    Müller-Kräuter H; Mezzacapo J; Klüver M; Baumgart S; Becker D; Fathi A; Pfeiffer S; Krähling V
    Med Microbiol Immunol; 2024 May; 213(1):6. PubMed ID: 38722338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High Prevalence of MERS-CoV Infection in Camel Workers in Saudi Arabia.
    Alshukairi AN; Zheng J; Zhao J; Nehdi A; Baharoon SA; Layqah L; Bokhari A; Al Johani SM; Samman N; Boudjelal M; Ten Eyck P; Al-Mozaini MA; Zhao J; Perlman S; Alagaili AN
    mBio; 2018 Oct; 9(5):. PubMed ID: 30377284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant Receptor-Binding Domains of Multiple Middle East Respiratory Syndrome Coronaviruses (MERS-CoVs) Induce Cross-Neutralizing Antibodies against Divergent Human and Camel MERS-CoVs and Antibody Escape Mutants.
    Tai W; Wang Y; Fett CA; Zhao G; Li F; Perlman S; Jiang S; Zhou Y; Du L
    J Virol; 2017 Jan; 91(1):. PubMed ID: 27795425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microneedle array delivered recombinant coronavirus vaccines: Immunogenicity and rapid translational development.
    Kim E; Erdos G; Huang S; Kenniston TW; Balmert SC; Carey CD; Raj VS; Epperly MW; Klimstra WB; Haagmans BL; Korkmaz E; Falo LD; Gambotto A
    EBioMedicine; 2020 May; 55():102743. PubMed ID: 32249203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Middle East Respiratory Syndrome Coronavirus Antibodies in Bactrian and Hybrid Camels from Dubai.
    Lau SKP; Li KSM; Luk HKH; He Z; Teng JLL; Yuen KY; Wernery U; Woo PCY
    mSphere; 2020 Jan; 5(1):. PubMed ID: 31969478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serologic Detection of Middle East Respiratory Syndrome Coronavirus Functional Antibodies.
    Okba NMA; Widjaja I; Li W; GeurtsvanKessel CH; Farag EABA; Al-Hajri M; Park WB; Oh MD; Reusken CBEM; Koopmans MPG; Bosch BJ; Haagmans BL
    Emerg Infect Dis; 2020 May; 26(5):1024-1027. PubMed ID: 32150528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of serological assays in human Middle East respiratory syndrome (MERS)-coronavirus infection.
    Park SW; Perera RA; Choe PG; Lau EH; Choi SJ; Chun JY; Oh HS; Song KH; Bang JH; Kim ES; Kim HB; Park WB; Kim NJ; Poon LL; Peiris M; Oh MD
    Euro Surveill; 2015; 20(41):. PubMed ID: 26538277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenicity of an adenoviral-based Middle East Respiratory Syndrome coronavirus vaccine in BALB/c mice.
    Kim E; Okada K; Kenniston T; Raj VS; AlHajri MM; Farag EA; AlHajri F; Osterhaus AD; Haagmans BL; Gambotto A
    Vaccine; 2014 Oct; 32(45):5975-82. PubMed ID: 25192975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cross-Protection against MERS-CoV by Prime-Boost Vaccination Using Viral Spike DNA and Protein.
    Choi JA; Goo J; Yang E; Jung DI; Lee S; Rho S; Jeong Y; Park YS; Park H; Moon YH; Park U; Seo SH; Lee H; Lee JM; Cho NH; Song M; Kim JO
    J Virol; 2020 Nov; 94(24):. PubMed ID: 32967955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of MERS-CoV Neutralizing Antibodies in Sera Using Live Virus Microneutralization Assay.
    Algaissi A; Hashem AM
    Methods Mol Biol; 2020; 2099():107-116. PubMed ID: 31883091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Middle East respiratory syndrome coronavirus (MERS-CoV) neutralising antibodies in a high-risk human population, Morocco, November 2017 to January 2018.
    Abbad A; Perera RA; Anga L; Faouzi A; Minh NNT; Malik SMMR; Iounes N; Maaroufi A; Van Kerkhove MD; Peiris M; Nourlil J
    Euro Surveill; 2019 Nov; 24(48):. PubMed ID: 31796154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ultrapotent Human Neutralizing Antibody Repertoires Against Middle East Respiratory Syndrome Coronavirus From a Recovered Patient.
    Niu P; Zhang S; Zhou P; Huang B; Deng Y; Qin K; Wang P; Wang W; Wang X; Zhou J; Zhang L; Tan W
    J Infect Dis; 2018 Sep; 218(8):1249-1260. PubMed ID: 29846635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Novel Nanobody Targeting Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Receptor-Binding Domain Has Potent Cross-Neutralizing Activity and Protective Efficacy against MERS-CoV.
    Zhao G; He L; Sun S; Qiu H; Tai W; Chen J; Li J; Chen Y; Guo Y; Wang Y; Shang J; Ji K; Fan R; Du E; Jiang S; Li F; Du L; Zhou Y
    J Virol; 2018 Sep; 92(18):. PubMed ID: 29950421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Feasibility of Using Convalescent Plasma Immunotherapy for MERS-CoV Infection, Saudi Arabia.
    Arabi YM; Hajeer AH; Luke T; Raviprakash K; Balkhy H; Johani S; Al-Dawood A; Al-Qahtani S; Al-Omari A; Al-Hameed F; Hayden FG; Fowler R; Bouchama A; Shindo N; Al-Khairy K; Carson G; Taha Y; Sadat M; Alahmadi M
    Emerg Infect Dis; 2016 Sep; 22(9):1554-61. PubMed ID: 27532807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of the Immune Response of MERS-CoV Vaccine Candidates Derived from Two Different Vectors in Mice.
    Li E; Yan F; Huang P; Chi H; Xu S; Li G; Liu C; Feng N; Wang H; Zhao Y; Yang S; Xia X
    Viruses; 2020 Jan; 12(1):. PubMed ID: 31968702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Searching for an ideal vaccine candidate among different MERS coronavirus receptor-binding fragments--the importance of immunofocusing in subunit vaccine design.
    Ma C; Wang L; Tao X; Zhang N; Yang Y; Tseng CK; Li F; Zhou Y; Jiang S; Du L
    Vaccine; 2014 Oct; 32(46):6170-6176. PubMed ID: 25240756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of human neutralizing monoclonal antibodies for prevention and therapy of MERS-CoV infections.
    Ying T; Li H; Lu L; Dimitrov DS; Jiang S
    Microbes Infect; 2015 Feb; 17(2):142-8. PubMed ID: 25456101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experimental Infection and Response to Rechallenge of Alpacas with Middle East Respiratory Syndrome Coronavirus.
    Crameri G; Durr PA; Klein R; Foord A; Yu M; Riddell S; Haining J; Johnson D; Hemida MG; Barr J; Peiris M; Middleton D; Wang LF
    Emerg Infect Dis; 2016 Jun; 22(6):1071-4. PubMed ID: 27070733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suggested new breakpoints of anti-MERS-CoV antibody ELISA titers: performance analysis of serologic tests.
    Ko JH; Müller MA; Seok H; Park GE; Lee JY; Cho SY; Ha YE; Baek JY; Kim SH; Kang JM; Kim YJ; Jo IJ; Chung CR; Hahn MJ; Drosten C; Kang CI; Chung DR; Song JH; Kang ES; Peck KR
    Eur J Clin Microbiol Infect Dis; 2017 Nov; 36(11):2179-2186. PubMed ID: 28695355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody-dependent enhancement (ADE) of SARS-CoV-2 in patients exposed to MERS-CoV and SARS-CoV-2 antigens.
    Thomas S; Smatti MK; Alsulaiti H; Zedan HT; Eid AH; Hssain AA; Abu Raddad LJ; Gentilcore G; Ouhtit A; Althani AA; Nasrallah GK; Grivel JC; Yassine HM
    J Med Virol; 2024 May; 96(5):e29628. PubMed ID: 38682568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.